Hypoparathyroidism

One of the most important things patients can do to manage these symptoms is to work with their healthcare team…

Patients with hypoparathyroidism in Australia can access publicly funded endocrinology services through the public health system.

For patients with hypoparathyroidism, seeing an endocrinologist is an important part of their care.

Nerve pain, or neuropathy, is a common symptom experienced by individuals with hypoparathyroidism. This condition occurs when there is a…

Managing pain associated with hypoparathyroidism can be challenging, but there are several strategies that can help alleviate discomfort and improve…

Living with hypoparathyroidism can pose several challenges, including the increased risk of developing kidney stones and kidney damage.

Hypoparathyroidism can have significant economic consequences for patients and their families, as well as for the wider healthcare system.

It is estimated that hypoparathyroidism affects approximately 1 in 2,000 people in the general population worldwide.

Encalaret has the potential to be a game-changing therapy for patients with hypoparathyroidism.

Encalaret is an investigational drug being studied for the treatment of hypoparathyroidism.